Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value ($000): $555,604 (100.0% shares, 0.0% debt)

Holdings (15)

BBIO BridgeBio Pharma Inc. (BBIO) 67.3%

Value ($000) $373,797 Shares 6,068,125 Est. Cost $40.43 Unrealized +61.8%

HRMY Harmony Biosciences Holdings Inc. (HRMY) 5.0%

Value ($000) $27,847 Shares 842,815 Est. Cost $36.46 Unrealized -3.8%

NUVB Nuvation Bio Inc. (NUVB) 4.8%

Value ($000) $26,554 Shares 2,541,009 Est. Cost $11.18 Unrealized 0.0%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 4.1%

Value ($000) $22,919 Shares 1,025,000 Est. Cost $10.24 Unrealized +120.6%

— Spruce Biosciences, Inc. (SPRB) 3.6%

Value ($000) $20,011 Shares 1,205,511 Est. Cost $24.31 Unrealized —

ACRS Aclaris Theraputics Inc. (ACRS) 2.9%

Value ($000) $15,988 Shares 634,455 Est. Cost $10.31 Unrealized +89.7%

— Aeglea Biotherapeutics Inc. (AGLE) 2.4%

Value ($000) $13,394 Shares 1,691,151 Est. Cost $8.00 Unrealized —

— AVROBIO, Inc. (AVRO) 2.3%

Value ($000) $12,814 Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Verona Pharma plc (VRNA) 2.0%

Value ($000) $11,140 Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 1.8%

Value ($000) $9,963 Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 1.3%

Value ($000) $7,040 Shares 3,142,857 Est. Cost $4.35 Unrealized —

— Atreca Inc. (BCEL) 1.1%

Value ($000) $5,943 Shares 387,653 Est. Cost $18.84 Unrealized —

— ObsEva SA (OBSV) 0.8%

Value ($000) $4,506 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.6%

Value ($000) $3,371 Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.1%

Value ($000) $317 Shares 191,028 Est. Cost $1.66 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$373,797	67.3%	$40.43	+61.8%	COM	10806X102
HRMY	Harmony Biosciences Holdings Inc. (HRMY)	842,815	$27,847	5.0%	$36.46	-3.8%	COM	413197104
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$26,554	4.8%	$11.18	0.0%	COM CL A	67080N101
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$22,919	4.1%	$10.24	+120.6%	COM	87164F105
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$20,011	3.6%	$24.31	—	COM	85209E109
ACRS	Aclaris Theraputics Inc. (ACRS)	634,455	$15,988	2.9%	$10.31	+89.7%	COM	00461U105
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$13,394	2.4%	$8.00	—	COM	00773J103
—	AVROBIO, Inc. (AVRO)	1,009,779	$12,814	2.3%	$16.72	—	COM	05455M100
—	Verona Pharma plc (VRNA)	1,332,485	$11,140	2.0%	$7.38	—	SPONSORED ADS	925050106
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$9,963	1.8%	$8.87	—	COM	73730P108
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$7,040	1.3%	$4.35	—	COM	57055L107
—	Atreca Inc. (BCEL)	387,653	$5,943	1.1%	$18.84	—	CL A COM	04965G109
—	ObsEva SA (OBSV)	1,386,338	$4,506	0.8%	$12.66	—	COM	H5861P103
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$3,371	0.6%	$2.15	—	COM NEW	98979H202
—	Nabriva Therapeutics plc (NBRV)	191,028	$317	0.1%	$1.66	—	SHS	G63637113